[218] Stieglitz, Julius: Synthetic Drugs II, J. A. M. A. 70:688 (March 9) 1918. Leech, P. N.: The Vindication of the American Chemist; Synthetic Drugs, Chicago Chem. Bull. January, 1918, p. 230.
[219] The Quality of American-Made Synthetics, J. A. M. A. 69:1018 (Sept. 22) 1917.
[220] This committee is composed of Julius Stieglitz, chairman, professor of chemistry, University of Chicago; W. A. Puckner, secretary of the Council on Pharmacy and Chemistry, American Medical Association, and Moses Gomberg, professor of chemistry, University of Michigan.
[221] Stieglitz, Julius: Shortage of Synthetic Remedies, J. A. M. A. 69:400 (Aug. 4) 1917.
[222] Foreign Patents to Be Open to American Manufacturers, J. A. M. A. 69:1550 (Nov. 3) 1917.
[223] For an interesting discussion, see Stieglitz, Julius: Synthetic Drugs, J. A. M. A. 70: 536 (Feb. 23); 688 (March 9); 923 (March 30) 1918. Bracken, L. L.: Federal Trade Commission Requests Use of Official Names, ibid. 70:558 (Feb. 23) 1918.
[224] The testing and standardizing of arsphenamin is being done by the Hygienic Laboratory, U. S. Public Health Service. For chemical tests see reprint 472, Public Health Reports. For a review of the patent literature see article by H. F. Lewis, J. Indust. Engin. Chem., Feb. 1, 1919, p. 141.
[225] New and Nonofficial Remedies, 1919, published by The Council on Pharmacy and Chemistry of the American Medical Association, p. 82.
[226] The pharmaceutic monograph on barbital has been omitted. It was published in the 1918 edition of the Annual Reports of the Chemical Laboratory of the American Medical Association.
[227] New and Nonofficial Remedies, 1918, p. 96.